Cancer diagnoses in England have reached a historic peak, with NHS data revealing that more than 1,000 people are now diagnosed with the disease every day.

According to the latest cancer registration statistics, over 373,000 people received a cancer diagnosis in England during 2024—the highest annual figure on record. This equates to a daily average of 1,021 diagnoses, up from 972 in 2023. Prostate, breast, lung, and bowel cancers accounted for half of all new cases.

The data indicates progress in early detection: 56.7% of cancers were identified at stages 1 and 2 in 2024, compared with 55.8% the previous year. Professor Peter Johnson, NHS national clinical director for cancer, said the figures demonstrate the health service is “moving in the right direction” and credited NHS staff for bringing tests and checks closer to communities.

However, experts warned that significant challenges remain. The NHS continues to miss key performance targets. In August, only 78.6% of patients urgently referred for suspected cancer were diagnosed or given the all-clear within 28 days, falling short of the 80% target. Treatment timelines are further behind: just 71.9% of patients began treatment within 62 days of an urgent referral, well below the 85% operational standard.

Dr Ian Walker, executive director of policy at Cancer Research UK, cautioned that despite increased diagnostic activity, too many cancers are still detected at a late stage. He urged the government to maintain momentum on its national cancer plan, emphasizing the need for specialist staff, equipment, and clear accountability to improve waiting times and early diagnosis rates.

Dr Hilary Williams, clinical vice-president at the Royal College of Physicians, highlighted the growing demand on oncology services driven by an ageing population and risk factors such as obesity. She stressed the importance of expanding targeted screening programmes, such as lung cancer checks, alongside prevention efforts.

Steven McIntosh, chief partnerships officer at Macmillan Cancer Support, noted that the aggregate figures mask persistent health inequalities, where demographics and geography significantly influence cancer risk, diagnostic speed, and survival outcomes.

Rachael Franklin, deputy chief executive of Breast Cancer Now, pointed out that breast cancer remains the leading cause of cancer death among working-age women in the UK, with one in seven women diagnosed in their lifetime. She encouraged breast awareness, prompt GP consultation for unusual changes, and attendance at screening appointments.

Source link

Exit mobile version